New immune therapy spares bladder in cancer patients
A recent medical study has shown that a new immunotherapy treatment helped patients suffering from a stubborn and proliferative type of bladder cancer avoid surgical removal of the bladder, which is the traditional option for treating advanced cases. The study involved 115 patients and demonstrated the effectiveness of the therapy developed by C.G. Oncology, as 81% of them did not require surgery after two years. Additionally, 75% achieved complete remission with no signs of cancer, and this remission lasted more than two years in about 60% of the patients. The treatment also helped maintain patients' quality of life, with only one case experiencing cancer recurrence after more than four years. This is a significant outcome that indicates improved treatment results and a reduced need for surgical removal.
Notice: This Is an AI-Generated Summary
Comments (0)